Your browser doesn't support javascript.
loading
Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents.
Wang, Lei; Wu, Zhiwei; Ying, Zhifang; Li, Minjie; Hu, Yuansheng; Shu, Qun; Li, Jing; Wang, Huixian; Zhang, Hengming; Jiao, Wenbin; Wang, Lin; Zhao, Yuliang; Gao, Qiang.
Afiliação
  • Wang L; National Immunisation Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu Z; Sinovac Biotech Ltd., Beijing, China.
  • Ying Z; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei Province, China.
  • Li M; National Institutes for Food and Drug Control, Beijing, China.
  • Hu Y; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei Province, China.
  • Shu Q; Sinovac Biotech Ltd., Beijing, China.
  • Li J; Beijing Key Tech Statistics Technology Co., Ltd., Beijing, China.
  • Wang H; Sinovac Life Sciences Co., Ltd., Beijing, China.
  • Zhang H; Zanhuang County Center for Disease Control and Prevention, Zanhuang, Hebei Province, China.
  • Jiao W; Sinovac Biotech Ltd., Beijing, China.
  • Wang L; Zanhuang County Center for Disease Control and Prevention, Zanhuang, Hebei Province, China.
  • Zhao Y; Sinovac Life Sciences Co., Ltd., Beijing, China.
  • Gao Q; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei Province, China. yuliang_zh1@163.com.
Nat Commun ; 13(1): 6952, 2022 11 14.
Article em En | MEDLINE | ID: mdl-36376310

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article